Hydroxyurea
FDA Approved
Contents
Description
Hydroxyurea is an antimetabolite used to treat certain cancers and sickle cell anemia. It inhibits DNA synthesis without affecting RNA or protein synthesis.
Indications & Therapeutic Use
Choriocarcinoma of ovary
Linked Diseases:
Global Availability (2 countries)
| Country | Access Route | Regulatory Pathway | Lead Time | Status |
|---|---|---|---|---|
| — | — | — | — | |
| — | — | — | — |
Buy / Source Hydroxyurea — GNH India
29 matching products available through GNH India. Select a product to view details and request a quote on the GNH India website.
APO-HYDROXYUREA
500 MGcapsuleCANADA
Curea
500mgcapsuleIndia
DROXIA 200mg
200mgcapsuleU.S.A
DROXIA
300mgcapsuleGermany
Droxia 300mg - USA
300mgcapsuleUSA
HYDREA
500mgcapsuleUSA
HYDROXYCARBAMID
500mgcapsuleSwitzerland
HYDROXYUREA 500
500mgcapsuleUSA
Products and ordering are fulfilled by GNH India. You will be redirected to www.gnhindia.com.
Available Through
This drug is available for procurement through the following fulfilment partner.
Fulfilment Partner
Hydroxyurea
| Generic Name | Hydroxyurea |
| Brands | 1 brand available |
| Active Ingredient | Hydroxyurea |
| Drug Class | Choriocarcinoma of ovary |
| Manufacturer | Bristol-Myers Squibb |
| Dosage Forms | Capsule |
| Medical Code | L01XX05 |
| Orphan Status | No |
| Cold Chain | Not Required |
| Reg. Status | FDA Approved |
| Countries | 2 countries |
Authority Signals
Last Verified3/21/2026
Data ConfidenceHigh (AI + Pharmacist)
Source Citations3 Validated Nodes